![]() | Up a level |
Journal Article
Welte, Tobias, Dellinger, R. Phillip, Ebelt, Henning, Ferrer, Miguel ORCID: 0000-0001-8171-6673, Opal, Steven M., Singer, Mervyn
ORCID: 0000-0002-1042-6350, Vincent, Jean-Louis
ORCID: 0000-0001-6011-6951, Werdan, Karl, Martin-Loeches, Ignacio, Almirall, Jordi
ORCID: 0000-0002-3821-4341, Artigas, Antonio, Ignacio Ayestaran, Jose, Nuding, Sebastian, Ferrer, Ricard
ORCID: 0000-0002-4859-4747, Sirgo Rodriguez, Gonzalo, Shankar-Hari, Manu
ORCID: 0000-0002-5338-2538, Alvarez-Lerma, Francisco, Riessen, Reimer, Sirvent, Josep-Maria, Kluge, Stefan, Zacharowski, Kai
ORCID: 0000-0002-0212-9110, Bonastre Mora, Juan, Lapp, Harald, Woebker, Gabriele, Achtzehn, Ute, Brealey, David, Kempa, Axel, Sanchez Garcia, Miguel, Brederlau, Joerg, Kochanek, Matthias, Reschreiter, Henrik Peer, Wise, Matthew P., Belohradsky, Bernd H., Bobenhausen, Iris, Dalken, Benjamin, Dubovy, Patrick, Langohr, Patrick, Mayer, Monika, Schuettrumpf, Joerg, Wartenberg-Demand, Andrea, Wippermann, Ulrike, Wolf, Daniele and Torres, Antoni
ORCID: 0000-0002-8643-2167
(2018).
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study).
Intensive Care Med., 44 (4).
S. 438 - 449.
NEW YORK:
SPRINGER.
ISSN 1432-1238